Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study.
Jurij HanželJeroen M JansenRinze W F Ter SteegeKrisztina B GecseGeert R D'HaensPublished in: Inflammatory bowel diseases (2021)
Multiple successive switching and switching between biosimilars of IFX seemed to be effective and safe.